<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Anesthesia for labor and delivery in high-risk heart disease: Specific lesions</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Anesthesia for labor and delivery in high-risk heart disease: Specific lesions</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Anesthesia for labor and delivery in high-risk heart disease: Specific lesions</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Katherine W Arendt, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David L Hepner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jonathan B Mark, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nancy A Nussmeier, MD, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jul 27, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3495363173"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Management of the parturient with high-risk cardiovascular disease ideally involves a high-risk pregnancy heart team that includes cardiologists, obstetricians, and anesthesiologists to develop an individualized management plan [<a href="#rid1">1-3</a>]. Interdisciplinary communication and preparation are critically important, since peripartum obstetric and cardiac complications may require urgent intervention.</p><p>This topic will discuss considerations for anesthetic management of patients with specific acquired and congenital heart lesions during labor and delivery, focusing on methods to minimize peripartum risk while providing optimal anesthetic care. Patients with complex cardiac disease or multiple lesions may have opposing hemodynamic impact (eg, combined mitral stenosis and mitral regurgitation). In such cases, the care team should focus on the specific lesion that is most severe and/or most likely to lead to hemodynamic deterioration.</p><p>General considerations for anesthetic management of obstetric patients with high-risk heart disease, including preanesthetic evaluation, monitoring considerations, and risks and benefits of neuraxial and general anesthetic techniques are discussed separately [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations"</a>.)</p><p class="headingAnchor" id="H240446634"><span class="h1">OBSTRUCTIVE LESIONS</span><span class="headingEndMark"> — </span>For parturients with obstructive cardiac lesions (eg, aortic stenosis [AS], mitral stenosis [MS], aortic coarctation, pulmonic valve or conduit stenosis), hemodynamic goals are to maintain sinus rhythm with a normal heart rate (HR), as well as adequate preload and systemic vascular resistance (SVR)  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease", section on 'Aortic stenosis'</a> and  <a class="medical medical_review" href="/z/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease", section on 'Mitral stenosis'</a>.)</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural is placed early in labor to attenuate pain-related catecholamine release that may increase HR and SVR. For cesarean delivery, a very slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable after insertion of an intra-arterial catheter for continuous blood pressure (BP) monitoring. A <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion is initiated at the time of needle placement and subsequently titrated to keep BP as close to baseline as possible. In patients with severe obstructive lesions, avoid spinal anesthesia due to the possibility of a rapidly induced sympathectomy leading to profound hypotension. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – While intravenous (IV) premedication (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>) is generally avoided in obstetric anesthesia because of newborn depression, it is reasonable to administer these agents in selected patients to ensure a hemodynamically smooth induction. Notify the neonatology team if these agents are administered at induction. Avoid administering doses of induction agents that are likely to cause significant tachycardia (eg, <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a>) (see  <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Ketamine'</a>) or vasodilation (eg, a standard bolus induction doses of <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a>. (See  <a class="medical medical_review" href="/z/d/html/94533.html" rel="external">"General anesthesia: Intravenous induction agents", section on 'Propofol'</a>.) </p><p></p><p class="bulletIndent1">While a titrated slow induction is generally avoided in obstetric anesthesia, it is reasonable to titrate the induction according to intra-arterial blood pressure monitoring in patients with obstructive cardiac lesions because the risks of hemodynamic alterations are greater than the risk of aspiration. </p><p></p><p class="bulletIndent1">Notably, adequate anesthetic depth should be established to blunt the sympathetic response to laryngoscopy and intubation. If necessary, a vasopressor such as <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> is administered to minimize or treat hypotension.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of complications:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Peripartum hemorrhage</strong> – If peripartum hemorrhage occurs, rapid treatment with fluid and blood resuscitation is appropriate, as well as cautious administration of appropriate uterotonic drugs when bleeding is related to atony. However, oxytocin causes a profound decrease in SVR, particularly if administered as an IV bolus dose. Therefore, oxytocin should not be bloused; rather, it is titrated via an infusion pump (eg, at 6 to 15 units/hour) with continuous BP monitoring, and immediate treatment of hypotension with a vasopressor [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/94367.html" rel="external">"Anesthesia for the patient with peripartum hemorrhage"</a> and  <a class="medical medical_review" href="/z/d/html/6714.html" rel="external">"Postpartum hemorrhage: Medical and minimally invasive management", section on 'Administer additional uterotonic medications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postpartum pulmonary edema</strong> – Patients with severe MS are at particularly high risk for rapid onset of pulmonary edema (ie, "flash" pulmonary edema) immediately after delivery. Contributing factors include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Aorto-caval decompression, which allows blood from the lower body to return rapidly to the heart</p><p class="bulletIndent3"><span class="glyph">-</span>Autotransfusion from the contracting evacuated uterus</p><p class="bulletIndent3"><span class="glyph">-</span>Tachycardia and atrial arrhythmias</p><p></p><p class="bulletIndent2">Although the increased venous capacitance caused by sympathetic blockade with neuraxial anesthesia helps to reduce this risk, the physiologic changes following delivery increase preload and left atrial pressure, which may result in pulmonary congestion. In the awake parturient, this may present as acute dyspnea, hypoxemia, orthopnea, and coughing. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent2">Treatment of flash pulmonary edema includes positioning the bed in the head-up position as much as possible and administering supplemental oxygen via mask. In patients with severe symptoms, an IV diuretic (eg, <a class="drug drug_general" data-topicid="8482" href="/z/d/drug information/8482.html" rel="external">furosemide</a>) is administered. Avoid <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> infusion in the immediate postpartum period since this may cause uterine atony with a significant increase in obstetric hemorrhage. If severe symptoms persist, it may be necessary to induce general anesthesia, intubate the trachea, and use positive pressure mechanical ventilation.</p><p></p><p class="headingAnchor" id="H855740842"><span class="h1">REGURGITANT LESIONS</span><span class="headingEndMark"> — </span>For parturients with a regurgitant cardiac lesion (eg, mitral, aortic, tricuspid, or pulmonic valve, or conduit regurgitation), hemodynamic goals include maintaining a normal to fast heart rate (HR), maintaining or decreasing systemic vascular resistance (SVR), and maintaining preload  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease", section on 'Aortic regurgitation'</a> and  <a class="medical medical_review" href="/z/d/html/93514.html" rel="external">"Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease", section on 'Mitral regurgitation'</a>.)</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong> – The inodilator <a class="drug drug_general" data-topicid="9652" href="/z/d/drug information/9652.html" rel="external">milrinone</a> is typically used to maintain cardiac output (CO) through a combination of peripheral dilation and increased contractility  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 2</a>). Acute<strong> </strong>increases in SVR are treated to avoid regurgitant flow and increase forward flow. <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">Nifedipine</a> (a calcium channel blocker), <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a> (a beta-blocker with alpha-blocking activity), <a class="drug drug_general" data-topicid="8528" href="/z/d/drug information/8528.html" rel="external">hydralazine</a> (a direct arteriolar vasodilator), and <a class="drug drug_general" data-topicid="9635" href="/z/d/drug information/9635.html" rel="external">methyldopa</a> (a centrally acting alpha-2 agonist) are typically used as these antihypertensive agents have been well-studied in clinical trials for parturients with preeclampsia  (<a class="graphic graphic_table graphicRef55212" href="/z/d/graphic/55212.html" rel="external">table 3</a>). However, a more rapidly acting intravenous (IV) vasodilator is sometimes necessary  (<a class="graphic graphic_table graphicRef110261" href="/z/d/graphic/110261.html" rel="external">table 4</a>). We typically titrate an IV infusion of the calcium channel blocker <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a> to achieve vasodilation and lower blood pressure (BP) during the antepartum and intrapartum periods  (<a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">table 5</a>). We initiate the infusion at 5 mg/hour and titrate it up to 15 mg/hour, waiting approximately 10 minutes between dose changes to observe the effects. Infusion of the calcium channel blocker <a class="drug drug_general" data-topicid="8911" href="/z/d/drug information/8911.html" rel="external">clevidipine</a> is an alternative option if a more rapid and titratable calcium channel blocker is preferred, although this agent has not been well studied in pregnant patients. </p><p></p><p class="bulletIndent1">Notably, <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a> and <a class="drug drug_general" data-topicid="9707" href="/z/d/drug information/9707.html" rel="external">nitroprusside</a> are uterine relaxants; thus, discontinuation of these agents after delivery is necessary to avoid uterine atony with resultant postpartum hemorrhage. Furthermore, since nitroprusside may cause fetal cyanide toxicity if administered in high doses<em> </em>over a prolonged time period, this agent is avoided. (See  <a class="medical medical_review" href="/z/d/html/8166.html" rel="external">"Acute aortic regurgitation in adults"</a> and  <a class="medical medical_review" href="/z/d/html/8170.html" rel="external">"Acute mitral regurgitation in adults"</a>.)</p><p></p><p class="bulletIndent1">Careful afterload reduction with regional anesthesia is beneficial. (See  <a class="medical medical_review" href="/z/d/html/89517.html" rel="external">"Overview of neuraxial anesthesia", section on 'Cardiovascular'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Considerations for chronic aortic or mitral regurgitation</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neuraxial anesthesia</strong> – Epidural labor analgesia<strong> </strong>is strongly recommended for labor and delivery to attenuate pain-related catecholamine release that may increase SVR. For cesarean delivery, patients with regurgitant lesions and normal ventricular function will usually tolerate either spinal or epidural anesthesia well because the decrease in afterload may beneficially reduce regurgitant volume and increase CO. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>General anesthesia</strong> – Careful titration of <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> is preferred for induction because of its ability to reduce SVR. Dosing of both induction and maintenance anesthetic agents should be adequate to avoid increased BP due to sympathetic stimulation during tracheal intubation and subsequent surgical stimulation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Considerations for acute aortic or mitral regurgitation</strong> – Parturients with acute onset of severe aortic or mitral regurgitation (eg, due to endocarditis, papillary muscle rupture) are unstable and will require tracheal intubation, controlled ventilation, and inotropic and/or vasodilator support. These patients also typically require emergency cardiac surgery, which may be timed with cesarean delivery, depending on gestational age at presentation. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Emergency cardiac surgery with concomitant cesarean delivery'</a>.)</p><p></p><p class="headingAnchor" id="H136552748"><span class="h1">RIGHT-TO-LEFT SHUNTING WITH CYANOSIS</span><span class="headingEndMark"> — </span>For parturients with cyanotic congenital heart disease and right-to-left shunting (eg, palliated single ventricle, atrial septal defect with pulmonic stenosis, unrepaired tetralogy of Fallot [infundibular or pulmonic valve stenosis with a ventricular septal defect]), hemodynamic goals are to maintain or increase systemic vascular resistance (SVR) while avoiding increases in pulmonary vascular resistance (PVR)  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Right-to-left shunt with cyanosis'</a>.) </p><p>Notably, patients with Eisenmenger's syndrome (ie, bidirectional intracardiac shunt and pulmonary arterial hypertension) are at particularly high risk for pregnancy-related morbidity and mortality [<a href="#rid6">6</a>]. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Initiation of extracorporeal membrane oxygenation'</a> and  <a class="medical medical_review" href="/z/d/html/139887.html" rel="external">"Pulmonary hypertension with congenital heart disease: Pregnancy and contraception"</a>.)</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of intravenous catheters</strong> – For any patient with cyanosis related to a right-to-left shunt, filters must be placed on all intravenous (IV) lines as a precaution to prevent venous air embolism and paradoxical arterial air embolism during right-to-left shunting.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management to minimize right-to-left shunting:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treat decreased SVR</strong> – If a vasoconstrictor is necessary to treat decreased SVR or hypotension, the alpha-adrenergic agonist <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> is administered as boluses or an infusion; <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> may be employed if phenylephrine is ineffective. Although <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">vasopressin</a> is typically preferred in patients with right-to-left shunting since it increases SVR without increasing PVR, this agent may be avoided during pregnancy due to lack of data regarding its effects on uteroplacental perfusion and its similar structure to oxytocin. However, after delivery of the fetus, vasopressin may be the agent of choice  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Right-to-left shunt with cyanosis'</a>.)</p><p></p><p class="bulletIndent2">Notably, there is a particularly high potential for decreases in SVR and hypotension immediately after delivery, and during initiation of post-delivery oxytocin therapy, particularly if a bolus dose of oxytocin is administered (see  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Administration of uterotonics'</a>). Therefore, this agent should be titrated via an infusion pump with continuous blood pressure (BP) monitoring, and hypotension is immediately treated with a vasoconstrictor [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/1415.html" rel="external">"Pregnancy in women with congenital heart disease: Specific lesions", section on 'Cyanotic congenital heart disease'</a> and  <a class="medical medical_review" href="/z/d/html/1422.html" rel="external">"Pregnancy in women with congenital heart disease: General principles", section on 'Cyanosis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prevent and treat increases in PVR</strong> – PaCO<sub>2</sub> is maintained at 28 to 30 mmHg during general anesthesia to maintain a low PVR. The uterotonic agent carboprost is avoided as it may cause significant increases in PVR. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural is placed early in labor to attenuate pain-related catecholamine release that may cause tachycardia. For cesarean delivery, a slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable after insertion of an intra-arterial catheter for continuous BP monitoring. A <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion is initiated at the time of epidural needle placement and subsequently titrated to keep BP as close to baseline as possible. Avoid spinal anesthesia in patients with severe right-to-left shunting because the rapid onset of a sympathectomy and consequent decrease in SVR worsens right-to-left shunting and cyanosis. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – Typically, induction is accomplished with <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> or <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a> combined with an opioid (<a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a>) [<a href="#rid7">7,8</a>]. Avoid anesthetic agents or techniques that decrease SVR (eg, large bolus doses of <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> or high concentrations of an inhalation anesthetic. (See  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Choice of induction agent'</a> and  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Maintenance'</a>.). </p><p></p><p class="headingAnchor" id="H250482044"><span class="h1">LEFT-TO-RIGHT SHUNTNG</span><span class="headingEndMark"> — </span>For parturients with predominantly left-to-right shunting (eg, atrial septal defect [ASD], ventricular septal defect [VSD], patent ductus arteriosus [PDA]), the emphasis is on maintaining systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR) at normal physiologic pressures  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Left-to-right shunt with pulmonary overcirculation'</a>.) </p><p>Compared with cyanotic congenital heart disease with right-to-left shunting, lesions with predominantly left-to-right shunting are typically better tolerated during labor and delivery, particularly in patients without significant pulmonary hypertension or severe impairment of ventricular function. However, marked reductions in SVR should be avoided or treated to avoid reversal of shunt direction to become right-to-left shunting. Vasopressors (eg, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>) are administered if necessary.</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of intravenous catheters</strong> – As noted above, for any patient with a shunt, filters must be placed on all intravenous lines as a precaution to prevent venous air embolism and paradoxical arterial air embolism since a temporary decrease in SVR could cause shunt reversal resulting in right-to-left shunting. (See <a class="local">'Right-to-left shunting with cyanosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural should be used for labor and delivery. For cesarean delivery, mild reductions in SVR due to a slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural are usually well-tolerated.</p><p></p><p class="headingAnchor" id="H1415519489"><span class="h1">FONTAN PHYSIOLOGY (CAVOPULMONARY PALLIATION)</span><span class="headingEndMark"> — </span>For parturients with Fontan physiology (a single ventricle that pumps blood to the systemic circulation, with passive nonpulsatile circulation to the pulmonary arterial system  (<a class="graphic graphic_figure graphicRef95320" href="/z/d/graphic/95320.html" rel="external">figure 1</a>) (see  <a class="medical medical_review" href="/z/d/html/122375.html" rel="external">"Overview of the management and prognosis of patients with Fontan circulation"</a>)), hemodynamic goals are to maintain adequate cardiac output (CO) and forward flow by maintaining preload, myocardial contractility, coronary perfusion,<em> </em>and sinus rhythm, while decreasing pulmonary vascular resistance (PVR)  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>) [<a href="#rid9">9-14</a>]. Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/99944.html" rel="external">"Anesthesia for adults with congenital heart disease undergoing noncardiac surgery", section on 'Fontan physiology (cavopulmonary palliation)'</a>.) </p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong> – Since Fontan patients are exquisitely sensitive to impaired venous return, it is important to [<a href="#rid15">15</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid aortocaval compression. Patients should be positioned in left uterine displacement or on their side while laboring when possible [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Assess the effects of pushing and the Valsalva maneuver during the second stage of labor. Some obstetricians continuously monitor heart rate (HR), blood pressure (BP), and oxygenation throughout a trial of pushing to assess whether hemodynamic stability is maintained. If hemodynamic compromise is noted, pushing can be modified from typical closed glottic pushing to open glottic pushing. </p><p></p><p class="bulletIndent2">Less commonly, the obstetrician may try to avoid decreases in venous return by minimizing use of the Valsalva maneuver, opting instead for a "passive second stage of labor." Prior communication with the obstetrician regarding this plan is essential because a passive second stage requires excellent sacral coverage via epidural analgesia.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid hypovolemia. Although we rarely insert a central venous catheter during labor and delivery, if central venous pressure (CVP) is to be monitored, it is maintained at 10 to 15 mmHg to maintain the transpulmonary gradient and facilitate pulmonary blood flow [<a href="#rid11">11,12,17</a>].</p><p></p><p class="bulletIndent2">If peripartum hemorrhage occurs, rapid treatment with fluid and blood resuscitation is appropriate, as well as administration of uterotonic drugs (eg, oxytocin, or <a class="drug drug_general" data-topicid="9657" href="/z/d/drug information/9657.html" rel="external">misoprostol</a>) if bleeding is related to atony. Avoid <a class="drug drug_general" data-topicid="9203" href="/z/d/drug information/9203.html" rel="external">carboprost tromethamine</a> in patients with Fontan circulation since this agent can cause a profound and sudden elevation in PVR. Likewise, <a class="drug drug_general" data-topicid="9637" href="/z/d/drug information/9637.html" rel="external">methylergonovine</a> is typically avoided since this agent can cause increases in PVR as well as systemic vascular resistance (SVR). (See  <a class="medical medical_review" href="/z/d/html/94367.html" rel="external">"Anesthesia for the patient with peripartum hemorrhage"</a> and  <a class="medical medical_review" href="/z/d/html/6714.html" rel="external">"Postpartum hemorrhage: Medical and minimally invasive management", section on 'Administer additional uterotonic medications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid spinal anesthesia to avoid a rapidly induced sympathectomy resulting in decreased venous return. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid positive end-expiratory pressure which may decrease venous return and increase PVR. In particular, avoid overinflation of the lungs; treat any evidence of bronchospasm promptly to avoid lung hyperinflation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – Epidural labor analgesia is recommended, particularly if the obstetrician plans to modify the second stage of labor through assisted vaginal delivery or by avoiding, minimizing, or modifying closed glottic pushing (ie, Valsalva maneuver) [<a href="#rid15">15,18</a>]. For cesarean delivery, a very slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable. Infusion of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> is initiated at the time of epidural needle placement and subsequently titrated to keep blood pressure (BP) as close to baseline as possible. As noted above, spinal anesthesia is avoided. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – To minimize risk of inducing hemodynamic instability, we slowly titrate the intravenous induction agent (typically <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> or <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a>), rather than proceeding with a rapid sequence induction and intubation. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'General anesthesia technique for cesarean delivery'</a> and  <a class="medical medical_review" href="/z/d/html/94214.html" rel="external">"Rapid sequence induction and intubation (RSII) for anesthesia"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postpartum complications</strong> – Postpartum hemorrhage is the most common obstetric complication in Fontan patients with Fontan physiology. This may be due to uterine atony with lesser use of uterotonic agents (see  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Effects of drugs commonly used in the labor unit'</a>), or underlying chronic liver dysfunction [<a href="#rid19">19,20</a>]. Other common peripartum complications are arrhythmias and heart failure [<a href="#rid19">19,21</a>].</p><p></p><p class="headingAnchor" id="H3951493793"><span class="h1">CARDIOMYOPATHIES</span><span class="headingEndMark"> — </span>Hemodynamic and anesthetic management of parturients with cardiomyopathy varies depending on the type of cardiomyopathy.</p><p>Presence of a biventricular pacemaker and/or implantable cardioverter-defibrillator device is common in patients with cardiomyopathy  (<a class="graphic graphic_algorithm graphicRef116023" href="/z/d/graphic/116023.html" rel="external">algorithm 1</a> and <a class="graphic graphic_algorithm graphicRef116028" href="/z/d/graphic/116028.html" rel="external">algorithm 2</a>). In patients with a history of poorly tolerated arrhythmias, external defibrillator pads are positioned during labor and delivery in case rapid cardioversion or defibrillation becomes necessary. Further details are described separately. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Management of implantable cardioverter defibrillators and pacemakers'</a> and  <a class="medical medical_review" href="/z/d/html/94293.html" rel="external">"Perioperative management of patients with a pacemaker or implantable cardioverter-defibrillator"</a>.)</p><p class="headingAnchor" id="H252769369"><span class="h2">Dilated cardiomyopathy</span><span class="headingEndMark"> — </span>For parturients with a dilated cardiomyopathy, including peripartum cardiomyopathy, hemodynamic goals are to maintain or increase cardiac output (CO) by maintaining contractility, a normal to fast heart rate (HR), and adequate preload and systemic vascular resistance (SVR)  (<a class="graphic graphic_table graphicRef97440" href="/z/d/graphic/97440.html" rel="external">table 6</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8148.html" rel="external">"Acquired heart disease and pregnancy", section on 'Cardiomyopathy'</a> and  <a class="medical medical_review" href="/z/d/html/4945.html" rel="external">"Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3507.html" rel="external">"Management of heart failure during pregnancy"</a>.)</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid hypovolemia. Peripartum hemorrhage may significantly decrease preload and require fluid and blood resuscitation. However, in a patient with dilated cardiomyopathy, particular care should be taken to avoid fluid overload which exacerbates congestive heart failure (CHF). Administration of <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> or <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a> may be necessary to maintain adequate BP during volume administration. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maintain SVR. Avoid spinal anesthesia due to the possibility of a rapidly induced sympathectomy. Notably, hypotension is particularly likely immediately after birth and during initiation of post-delivery oxytocin therapy; thus, oxytocin administration is titrated using an infusion pump [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Administration of uterotonics'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural is optimal for labor. For cesarean delivery, a slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable. A <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion is initiated at the time of epidural needle placement and subsequently titrated to keep blood pressure (BP) as close to baseline as possible. As noted above, spinal anesthesia is avoided. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – We prefer induction with <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> 0.2 to 0.3 mg/kg supplemented with an opioid (eg, <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> 1 to 3 mcg/kg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 2 to 8 mcg/kg) to avoid a sudden decrease in SVR and subsequent hemodynamic collapse. A reasonable alternative is induction with slowly and carefully titrated <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> administered in combination with <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> or <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> administered as needed to maintain adequate BP. Avoid agents and doses causing myocardial depression (eg, high doses of propofol or volatile anesthetic agents). It may be necessary to administer inotropic agent(s) in a patient with severe left ventricular (LV) systolic dysfunction  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/91654.html" rel="external">"Intraoperative management for noncardiac surgery in patients with heart failure", section on 'Use of vasoactive and inotropic agents'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'General anesthesia technique for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1">Transesophageal echocardiography (TEE) may be useful during general anesthesia to assess ventricular function as well as volume status. (See  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Volume status'</a> and  <a class="medical medical_review" href="/z/d/html/14943.html" rel="external">"Intraoperative transesophageal echocardiography for noncardiac surgery", section on 'Ventricular function'</a>.)</p><p></p><p class="headingAnchor" id="H58268891"><span class="h2">Cardiomyopathy associated with preeclampsia</span><span class="headingEndMark"> — </span>Preeclampsia is associated with peripartum and idiopathic cardiomyopathy, often with diastolic dysfunction that limits the patient’s ability to increase stroke volume  (<a class="graphic graphic_table graphicRef139212" href="/z/d/graphic/139212.html" rel="external">table 7</a>) [<a href="#rid22">22,23</a>]. If pulmonary edema develops, prompt vaginal or cesarean delivery is often indicated since this is the only cure for preeclampsia. Details regarding anesthetic management during labor and delivery are available in a separate topic. (See  <a class="medical medical_review" href="/z/d/html/94369.html" rel="external">"Anesthesia for the patient with preeclampsia"</a>.) </p><p class="headingAnchor" id="H327450595"><span class="h2">Hypertrophic cardiomyopathy (HCM)</span><span class="headingEndMark"> — </span>Hemodynamic goals for parturients with hypertrophic cardiomyopathy (HCM) differ from goals for other types of cardiomyopathy. To avoid worsening left ventricular outflow tract (LVOT) obstruction, increases in myocardial contractility are avoided, while sinus rhythm, preload, and SVR are maintained. Also, maintaining diastolic BP &gt;70 mmHg ensures adequate coronary perfusion of the hypertrophied LV  (<a class="graphic graphic_table graphicRef97442" href="/z/d/graphic/97442.html" rel="external">table 8</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/114418.html" rel="external">"Anesthesia for patients with hypertrophic cardiomyopathy undergoing noncardiac surgery", section on 'Hemodynamic goals and management'</a>.)</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid hypovolemia. If peripartum hemorrhage occurs, rapid treatment with fluid and blood resuscitation is appropriate, as well as administration of uterotonic drugs if bleeding is related to atony. (See  <a class="medical medical_review" href="/z/d/html/94367.html" rel="external">"Anesthesia for the patient with peripartum hemorrhage"</a> and  <a class="medical medical_review" href="/z/d/html/6714.html" rel="external">"Postpartum hemorrhage: Medical and minimally invasive management", section on 'Administer additional uterotonic medications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid decreases in SVR. Avoid spinal anesthesia due to the possibility of a rapidly induced sympathectomy. Hypotension is particularly likely immediately after birth and during initiation of post-delivery oxytocin therapy; thus, oxytocin administration is titrated using an infusion pump [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/z/d/html/4480.html" rel="external">"Anesthesia for cesarean delivery", section on 'Administration of uterotonics'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoid administration of inotropic agents (eg, <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>, <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, and <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 2</a>)) to avoid increases in myocardial contractility; likewise, avoid sympathetic stimulation. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><a class="drug drug_general" data-topicid="9977" href="/z/d/drug information/9977.html" rel="external">Terbutaline</a> (a rapidly acting and short-acting beta-2 agonist) is contraindicated during labor since it may cause exacerbation of LVOT obstruction. Although obstetricians often administer an intramuscular dose of terbutaline 0.25 mg as a rescue treatment for uterine hyperstimulation or tachysystole if fetal distress is present, a hemodynamic crisis due to rapid increase in maternal HR and peripheral vasodilation may occur due to the sudden onset of beta-2 agonism caused by this typical dose of terbutaline. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural is placed early in labor to attenuate pain-related catecholamine release that may increase contractility and HR. The specific technique used for the test dose should be carefully considered. Subsequently, the analgesic block should be sufficiently dense to avoid labor pain. Avoid spinal anesthesia as noted above. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1">For cesarean delivery, a slowly titrated epidural anesthetic or a low-dose sequential combined spinal-epidural is reasonable (after an intra-arterial catheter has been inserted for continuous BP monitoring). However, at the time of intrathecal injection, a <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion is initiated at approximately 0.5 mcg/kg per minute and subsequently titrated to keep the BP as close to baseline as possible. If phenylephrine is ineffective, <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a> can be administered. <a class="drug drug_general" data-topicid="10039" href="/z/d/drug information/10039.html" rel="external">Vasopressin</a> is typically avoided during pregnancy due to absence of data regarding its effects on uteroplacental perfusion and also because of its similar structure to oxytocin. However, after delivery of the fetus, vasopressin can be considered an option  (<a class="graphic graphic_table graphicRef119747" href="/z/d/graphic/119747.html" rel="external">table 2</a>). As noted above, spinal anesthesia is avoided. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Test dose administration'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – A reasonable approach is administration of an induction agent (eg, <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> or <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a>) together with low doses of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> [<a href="#rid24">24</a>], and an opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>, <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a>) (see  <a class="medical medical_review" href="/z/d/html/130113.html" rel="external">"Perioperative uses of intravenous opioids: Specific agents", section on 'Fentanyl'</a> and  <a class="medical medical_review" href="/z/d/html/130113.html" rel="external">"Perioperative uses of intravenous opioids: Specific agents", section on 'Remifentanil'</a>). Avoid induction agents that cause tachycardia (eg, <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a>) or decrease SVR (eg, high doses of propofol), but establish adequate anesthetic depth to minimize sympathetic stimulation and tachycardia during laryngoscopy and intubation. Beta blockers (eg, <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">esmolol</a>, <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a>) are often used to control HR and beneficially decrease contractility, particularly during induction and intubation, and also during emergence and extubation [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/z/d/html/114418.html" rel="external">"Anesthesia for patients with hypertrophic cardiomyopathy undergoing noncardiac surgery", section on 'Induction'</a>.)</p><p></p><p class="bulletIndent1">During general anesthesia, TEE monitoring is particularly useful for continuous assessment of volume status, LVOT obstruction, LV cavity size and function, presence of mitral regurgitation, and global or regional myocardial ischemia, particularly if hemodynamic instability develops. (See  <a class="medical medical_review" href="/z/d/html/94296.html" rel="external">"Intraoperative rescue transesophageal echocardiography (TEE)", section on 'Left ventricular outflow tract obstruction'</a>.)</p><p></p><p class="headingAnchor" id="H3792844899"><span class="h2">Pulmonary hypertension and/or right heart failure</span><span class="headingEndMark"> — </span>Severe pulmonary arterial hypertension (PAH) carries a high risk of maternal mortality because the increased CO required to sustain pregnancy may not be accommodated in a patient with fixed pulmonary vascular resistance (PVR) and right heart failure [<a href="#rid26">26</a>]. As CO increases during the first trimester, patients with severe PAH may begin to decompensate and become hypoxemic. In some cases, delivery may become necessary prior to completion of a full-term pregnancy (or dilation and curettage or dilation and evacuation procedures may be performed during the first trimester) [<a href="#rid27">27</a>]. The postpartum period is the highest risk for patients with severe pulmonary hypertension, and these patients require close monitoring following delivery. In patients with peripartum acute pulmonary hypertensive crisis, invasive monitoring is typically employed (eg, intra-arterial catheter, pulmonary artery catheter) to guide therapy. In rare cases, cardiopulmonary resuscitation and extracorporeal membrane oxygenation (ECMO) may become necessary during pregnancy or the peripartum period [<a href="#rid27">27</a>]. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Mechanical circulatory support in pregnancy'</a> and  <a class="medical medical_review" href="/z/d/html/139887.html" rel="external">"Pulmonary hypertension with congenital heart disease: Pregnancy and contraception", section on 'Management of pregnancy'</a>.)</p><p>Details regarding anesthetic management of patients with pulmonary hypertension and right heart failure are discussed separately  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/94362.html" rel="external">"Anesthesia for noncardiac surgery in patients with pulmonary hypertension or right heart failure"</a>.)</p><p class="headingAnchor" id="H3300553346"><span class="h1">ISCHEMIC HEART DISEASE</span><span class="headingEndMark"> — </span>For parturients with ischemic heart disease, hemodynamic goals are to optimize myocardial oxygen supply and minimize myocardial oxygen demand by maintaining a normal heart rate (HR), as well as adequate preload and systemic vascular resistance (SVR)  (<a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">table 9</a> and <a class="graphic graphic_table graphicRef97439" href="/z/d/graphic/97439.html" rel="external">table 10</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/90616.html" rel="external">"Anesthesia for noncardiac surgery in patients with ischemic heart disease", section on 'Anesthetic goals'</a>.)</p><p>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural is placed early in labor to attenuate pain-related catecholamine release that may increase HR. For cesarean delivery, either spinal or epidural anesthesia is usually tolerated if hypotension is avoided or treated promptly. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia </strong>– Avoid induction agents that cause tachycardia (eg, <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">ketamine</a>) or vasodilation (eg, high bolus doses of <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a>), but establish adequate anesthetic depth to minimize tachycardia due to sympathetic stimulation during laryngoscopy and intubation. Beta blockers are often used to avoid or treat tachycardia and hypertension during laryngoscopy and subsequent surgical stimulation, and/or during emergence and tracheal extubation. Some clinicians use the short-acting opioid <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> as a supplemental agent during and after induction to avoid tachycardia without risk of causing prolonged neonatal respiratory depression. (See  <a class="medical medical_review" href="/z/d/html/130113.html" rel="external">"Perioperative uses of intravenous opioids: Specific agents", section on 'Remifentanil'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'General anesthesia technique for cesarean delivery'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of complications:</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Peripartum hemorrhage</strong> – If peripartum hemorrhage occurs, rapid treatment with fluid and blood resuscitation is appropriate, as well as cautious administration of uterotonic drugs if bleeding is related to atony. (See  <a class="medical medical_review" href="/z/d/html/94367.html" rel="external">"Anesthesia for the patient with peripartum hemorrhage"</a> and  <a class="medical medical_review" href="/z/d/html/6714.html" rel="external">"Postpartum hemorrhage: Medical and minimally invasive management", section on 'Administer additional uterotonic medications'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute myocardial infarction</strong> – In rare cases, parturients with acute myocardial infarction may require emergency cardiac surgery and concomitant cesarean delivery. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Emergency cardiac surgery with concomitant cesarean delivery'</a>.)</p><p></p><p class="headingAnchor" id="H252769402"><span class="h1">AORTIC ANEURYSM OR DISSECTION</span><span class="headingEndMark"> — </span>For parturients with a dilated ascending aorta and those at risk for aortic dissection (eg, Marfan syndrome), hemodynamic goals are to maintain a normal heart rate (HR) and blood pressure (BP) and adequate preload, while avoiding increases in systemic vascular resistance (SVR) or myocardial contractility  (<a class="graphic graphic_table graphicRef97443" href="/z/d/graphic/97443.html" rel="external">table 11</a>). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/8129.html" rel="external">"Heritable thoracic aortic diseases: Pregnancy and postpartum care", section on 'Delivery'</a>.)</p><p class="headingAnchor" id="H2007321694"><span class="h2">Marfan syndrome</span><span class="headingEndMark"> — </span>Specific considerations for anesthetic management during labor and delivery include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Monitoring</strong> – Throughout labor and delivery, continuous monitoring of pulse oximetry with a visible waveform, 5-lead electrocardiogram, and BP via an intra-arterial catheter should be employed. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Monitoring'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Intravascular catheters'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic management</strong> – The priority is control of BP and HR throughout labor and delivery. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Continue beta blockers initiated during pregnancy to maintain slow to normal HR and to prevent increases in BP.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Treat increases in BP or myocardial contractility (eg, due to sympathetic stimulation) with:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Intravenous (IV) beta blockers. <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">Esmolol</a> has the advantage of a short half-life, enabling titration to effect. Other reasonable choices include <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a> or <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a>  (<a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">table 5</a>).</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>If necessary for acute management to control BP, a vasodilator (eg, <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a>, <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a>, <a class="drug drug_general" data-topicid="8911" href="/z/d/drug information/8911.html" rel="external">clevidipine</a>) can be administered  (<a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">table 5</a>). However, nitroglycerin and <a class="drug drug_general" data-topicid="9707" href="/z/d/drug information/9707.html" rel="external">nitroprusside</a> are uterine relaxants that can cause uterine atony and resultant postpartum hemorrhage; thus, discontinuation after delivery is necessary. Furthermore, nitroprusside is typically avoided as it may cause fetal cyanide toxicity. (See  <a class="medical medical_review" href="/z/d/html/8129.html" rel="external">"Heritable thoracic aortic diseases: Pregnancy and postpartum care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuraxial anesthesia</strong> – An epidural is placed early in labor prior to significant pain-related catecholamine release which would increase BP and aortic wall stress. Thereafter, the analgesic block should be sufficiently dense to avoid sympathetic stimulation from labor pain. Notably, the presence of dural ectasia in a patient with Marfan’s syndrome should be considered  (<a class="graphic graphic_diagnosticimage graphicRef95679" href="/z/d/graphic/95679.html" rel="external">image 1</a>) [<a href="#rid28">28</a>]. Although dural ectasia is not a contraindication for epidural anesthesia, risk of dural puncture or inadequate anesthesia is more likely due to the increased volume of cerebrospinal fluid [<a href="#rid29">29,30</a>]. Performing the epidural technique in the lateral decubitus position may reduce risk for extension of the ectatic dural sac into the epidural space [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/z/d/html/8150.html" rel="external">"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders", section on 'Dural ectasia'</a> and  <a class="medical medical_review" href="/z/d/html/8129.html" rel="external">"Heritable thoracic aortic diseases: Pregnancy and postpartum care", section on 'Delivery'</a>.)</p><p></p><p class="bulletIndent1">Furthermore, the specific technique used for the test dose should be carefully considered. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Test dose administration'</a>.) </p><p></p><p class="bulletIndent1">For cesarean delivery, spinal, epidural, or low-dose sequential combined spinal-epidural anesthesia can be used with continuous monitoring of intra-arterial BP. Allowing the BP to drop as much as 20 percent below baseline after neuraxial anesthesia is reasonable. However, lower BP may result in uteroplacental insufficiency and fetal distress. A <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> infusion can be titrated to prevent and treat more severe decreases in BP. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial analgesia for labor'</a> and  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Neuraxial anesthesia for cesarean delivery'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General anesthesia</strong> – Induction with <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> supplemented with adjuvant agents (eg, an opioid such as <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> or <a class="drug drug_general" data-topicid="9854" href="/z/d/drug information/9854.html" rel="external">remifentanil</a> plus <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a>) is reasonable. <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> is contraindicated because of its sympathomimetic effects. Subsequently, adequate depth of anesthesia is maintained with a volatile anesthetic agent. Beta blockers and/or vasodilators may be used to control BP  (<a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">table 5</a>). (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'General anesthesia technique for cesarean delivery'</a>.)</p><p></p><p class="bulletIndent1">During general anesthesia, transesophageal echocardiography (TEE) monitoring is useful to localize any aortic intimal tear and resultant valvular dysfunction (ie, acute aortic regurgitation) or myocardial ischemia. (See <a class="local">'Acute aortic dissection'</a> below.)</p><p></p><p class="bulletIndent1">During emergence and tracheal extubation, hypertension may lead to aortic dissection. Risk is lessened by optimizing perioperative analgesia and by administering beta blockers and/or vasodilating agents.</p><p></p><p class="headingAnchor" id="H437688843"><span class="h2">Acute aortic dissection</span><span class="headingEndMark"> — </span>If ascending aortic dissection occurs during pregnancy, labor, or delivery, immediate cardiovascular surgical intervention is usually warranted because of the high risk of maternal mortality [<a href="#rid31">31,32</a>]. Management of the fetus depends on the stage of pregnancy; emergency cardiac surgery with concomitant cesarean delivery is often preferred due to the high risk of fetal loss during complex aortic surgery. (See  <a class="medical medical_review" href="/z/d/html/4446.html" rel="external">"Anesthesia for labor and delivery in high-risk heart disease: General considerations", section on 'Emergency cardiac surgery with concomitant cesarean delivery'</a>.) </p><p>Anesthetic management includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Ensure large-bore intravascular access and a functioning intra-arterial catheter. Also, plan insertion of a central venous catheter for administration of intravenous vasoactive drugs and to provide large-bore secure intravascular access for volume resuscitation. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Administer preoperative and intraoperative pharmacologic therapy to control BP until the patient is on cardiopulmonary bypass. Initial treatment is with IV beta blockers (eg, <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">esmolol</a>, <a class="drug drug_general" data-topicid="9540" href="/z/d/drug information/9540.html" rel="external">labetalol</a>, <a class="drug drug_general" data-topicid="9645" href="/z/d/drug information/9645.html" rel="external">metoprolol</a>) to reduce HR to &lt;60 beats/minute, reduce systolic BP, and minimize aortic wall stress  (<a class="graphic graphic_table graphicRef119750" href="/z/d/graphic/119750.html" rel="external">table 5</a>). If systolic BP remains &gt;100 mmHg after beta blockade, vasodilators (eg, <a class="drug drug_general" data-topicid="9706" href="/z/d/drug information/9706.html" rel="external">nitroglycerin</a>, <a class="drug drug_general" data-topicid="9697" href="/z/d/drug information/9697.html" rel="external">nicardipine</a>, <a class="drug drug_general" data-topicid="8911" href="/z/d/drug information/8911.html" rel="external">clevidipine</a>) are administered to achieve control. </p><p></p><p>Further details regarding management of acute aortic dissection are discussed in other topics. (See  <a class="medical medical_review" href="/z/d/html/8178.html" rel="external">"Overview of acute aortic dissection and other acute aortic syndromes", section on 'Acute medical management'</a> and  <a class="medical medical_review" href="/z/d/html/8188.html" rel="external">"Management of acute type B aortic dissection", section on 'Anti-impulse therapy'</a> and  <a class="medical medical_review" href="/z/d/html/8129.html" rel="external">"Heritable thoracic aortic diseases: Pregnancy and postpartum care", section on 'Management of aortic dissection'</a> and  <a class="medical medical_review" href="/z/d/html/120327.html" rel="external">"Management of acute type A aortic dissection", section on 'Acute management'</a>.)</p><p class="headingAnchor" id="H3923042511"><span class="h1">PREVIOUS HEART TRANSPLANTATION</span><span class="headingEndMark"> — </span>For parturients who have undergone heart transplantation prior to becoming pregnant, loss of cardiac autonomic enervation results in pharmacologic and hemodynamic changes. Notably, these parturients are extremely dependent on adequate intravascular volume and preload. Furthermore, direct-acting vasopressor agents to treat hypotension (eg, <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a>) are effective, but indirect agents that exert their effects via the autonomic nervous system (eg, <a class="drug drug_general" data-topicid="9114" href="/z/d/drug information/9114.html" rel="external">ephedrine</a>) are ineffective in the denervated heart. In addition, ventricular dysfunction and ischemic heart disease are often present (see <a class="local">'Ischemic heart disease'</a> above). Details are provided elsewhere. (See  <a class="medical medical_review" href="/z/d/html/122465.html" rel="external">"Anesthetic considerations after heart transplantation"</a>.) </p><p class="headingAnchor" id="H1866708188"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/115814.html" rel="external">"Society guideline links: Perioperative cardiovascular evaluation and management"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/131710.html" rel="external">"Society guideline links: Obstetric anesthesia"</a>.)</p><p class="headingAnchor" id="H87110961"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Specific cardiac lesions</strong> – Symptomatic or severe acquired or congenital heart lesions requiring specialized anesthetic management during labor and delivery include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Obstructive lesions</strong> – Examples include aortic stenosis, mitral stenosis, aortic coarctation, pulmonic valve or conduit stenosis  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). (See <a class="local">'Obstructive lesions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Regurgitant lesions</strong> – Examples include acute or chronic mitral, aortic, tricuspid, or pulmonic valve regurgitation, or conduit regurgitation  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). (See <a class="local">'Regurgitant lesions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cyanotic congenital heart disease</strong> <strong>with right-to-left shunting</strong> – Examples include palliated single ventricle, atrial septal defect (ASD) with pulmonic stenosis, Eisenmenger syndrome, and unrepaired tetralogy of Fallot  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). (See <a class="local">'Right-to-left shunting with cyanosis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Left-to-right shunting</strong> – Examples include atrial septal defect (ASD), ventricular septal defect (VSD), or patent ductus arteriosus (PDA)  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). (See <a class="local">'Left-to-right shuntng'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Fontan physiology</strong> – Fontan physiology involves a single ventricle that pumps blood to the systemic circulation, with passive nonpulsatile circulation to the pulmonary arterial system  (<a class="graphic graphic_figure graphicRef95320" href="/z/d/graphic/95320.html" rel="external">figure 1</a> and <a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>). (See <a class="local">'Fontan physiology (cavopulmonary palliation)'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiomyopathies</strong> – Hemodynamic and anesthetic management of parturients with cardiomyopathy varies depending on the type of cardiomyopathy:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Dilated cardiomyopathy </strong> (<a class="graphic graphic_table graphicRef97440" href="/z/d/graphic/97440.html" rel="external">table 6</a>) – (See <a class="local">'Dilated cardiomyopathy'</a> above.)</p><p class="bulletIndent3"><span class="glyph">-</span><strong>Cardiomyopathy associated with preeclampsia</strong> –  (<a class="graphic graphic_table graphicRef139212" href="/z/d/graphic/139212.html" rel="external">table 7</a>) (See <a class="local">'Cardiomyopathy associated with preeclampsia'</a> above.)</p><p class="bulletIndent3"><span class="glyph">-</span><strong>Hypertrophic cardiomyopathy</strong>  (<a class="graphic graphic_table graphicRef97442" href="/z/d/graphic/97442.html" rel="external">table 8</a>) – (See <a class="local">'Hypertrophic cardiomyopathy (HCM)'</a> above.)</p><p class="bulletIndent3"><span class="glyph">-</span><strong>Pulmonary hypertension with right heart failure</strong>  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>) – (See <a class="local">'Pulmonary hypertension and/or right heart failure'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Ischemic heart disease</strong>  (<a class="graphic graphic_table graphicRef91907" href="/z/d/graphic/91907.html" rel="external">table 9</a> and <a class="graphic graphic_table graphicRef97439" href="/z/d/graphic/97439.html" rel="external">table 10</a>) – (See <a class="local">'Ischemic heart disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Aortic aneurysm or dissection</strong> –  (<a class="graphic graphic_table graphicRef97443" href="/z/d/graphic/97443.html" rel="external">table 11</a>) </p><p></p><p class="bulletIndent3"><span class="glyph">-</span><strong>Marfan syndrome</strong> – (See <a class="local">'Marfan syndrome'</a> above.)</p><p class="bulletIndent3"><span class="glyph">-</span><strong>Acute aortic dissection</strong> – (See <a class="local">'Acute aortic dissection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Previous heart transplantation</strong>  (<a class="graphic graphic_table graphicRef105123" href="/z/d/graphic/105123.html" rel="external">table 1</a>) – (See <a class="local">'Previous heart transplantation'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists' Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease. Obstet Gynecol 2019; 133:e320.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165.</a></li><li><a class="nounderline abstract_t">Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019; 139:e698.</a></li><li><a class="nounderline abstract_t">Meng ML, Arendt KW. Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations. Anesthesiology 2021; 135:164.</a></li><li><a class="nounderline abstract_t">Dyer RA, Butwick AJ, Carvalho B. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist. Curr Opin Anaesthesiol 2011; 24:255.</a></li><li><a class="nounderline abstract_t">Lopez BM, Malhamé I, Davies LK, et al. Eisenmenger Syndrome in Pregnancy: A Management Conundrum. J Cardiothorac Vasc Anesth 2020; 34:2813.</a></li><li><a class="nounderline abstract_t">Orme RM, Grange CS, Ainsworth QP, Grebenik CR. General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases. Int J Obstet Anesth 2004; 13:183.</a></li><li><a class="nounderline abstract_t">Ngan Kee WD, Khaw KS, Ma KC, et al. Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial. Anesthesiology 2006; 104:14.</a></li><li><a class="nounderline abstract_t">McNamara JR, McMahon A, Griffin M. Perioperative Management of the Fontan Patient for Cardiac and Noncardiac Surgery. J Cardiothorac Vasc Anesth 2022; 36:275.</a></li><li><a class="nounderline abstract_t">McCabe M, An N, Aboulhosn J, et al. Anesthetic management for the peripartum care of women with Fontan physiology. Int J Obstet Anesth 2021; 48:103210.</a></li><li><a class="nounderline abstract_t">Eagle SS, Daves SM. The adult with Fontan physiology: systematic approach to perioperative management for noncardiac surgery. J Cardiothorac Vasc Anesth 2011; 25:320.</a></li><li><a class="nounderline abstract_t">Yuki K, Casta A, Uezono S. Anesthetic management of noncardiac surgery for patients with single ventricle physiology. J Anesth 2011; 25:247.</a></li><li><a class="nounderline abstract_t">Jolley M, Colan SD, Rhodes J, DiNardo J. Fontan physiology revisited. Anesth Analg 2015; 121:172.</a></li><li><a class="nounderline abstract_t">Ohuchi H. Adult patients with Fontan circulation: What we know and how to manage adults with Fontan circulation? J Cardiol 2016; 68:181.</a></li><li><a class="nounderline abstract_t">Uebing A, Steer PJ, Yentis SM, Gatzoulis MA. Pregnancy and congenital heart disease. BMJ 2006; 332:401.</a></li><li><a class="nounderline abstract_t">Lee SW, Khaw KS, Ngan Kee WD, et al. Haemodynamic effects from aortocaval compression at different angles of lateral tilt in non-labouring term pregnant women. Br J Anaesth 2012; 109:950.</a></li><li><a class="nounderline abstract_t">Krishnan US, Taneja I, Gewitz M, et al. Peripheral vascular adaptation and orthostatic tolerance in Fontan physiology. Circulation 2009; 120:1775.</a></li><li><a class="nounderline abstract_t">Jooste EH, Haft WA, Ames WA, et al. Anesthetic care of parturients with single ventricle physiology. J Clin Anesth 2013; 25:417.</a></li><li><a class="nounderline abstract_t">Garcia Ropero A, Baskar S, Roos Hesselink JW, et al. Pregnancy in Women With a Fontan Circulation: A Systematic Review of the Literature. Circ Cardiovasc Qual Outcomes 2018; 11:e004575.</a></li><li><a class="nounderline abstract_t">Saito J, Noguchi S, Nakai K, et al. General Anesthetic Management for Emergency Cesarean Section and Postpartum Hemorrhage in a Woman With Fontan Circulation. J Cardiothorac Vasc Anesth 2019; 33:791.</a></li><li><a class="nounderline abstract_t">Egbe AC, Khan AR, Ammash NM, et al. Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures. Heart 2017; 103:1813.</a></li><li><a class="nounderline abstract_t">Gammill HS, Chettier R, Brewer A, et al. Cardiomyopathy and Preeclampsia. Circulation 2018; 138:2359.</a></li><li><a class="nounderline abstract_t">Tihtonen K, Kööbi T, Yli-Hankala A, et al. Maternal haemodynamics in pre-eclampsia compared with normal pregnancy during caesarean delivery. BJOG 2006; 113:657.</a></li><li><a class="nounderline abstract_t">El-Tahan MR, Warda OM, Diab DG, et al. A randomized study of the effects of perioperative i.v. lidocaine on hemodynamic and hormonal responses for cesarean section. J Anesth 2009; 23:215.</a></li><li><a class="nounderline abstract_t">Gajewski M, Hillel Z. Anesthesia management of patients with hypertrophic obstructive cardiomyopathy. Prog Cardiovasc Dis 2012; 54:503.</a></li><li><a class="nounderline abstract_t">McGlothlin DP, Granton J, Klepetko W, et al. ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery. J Heart Lung Transplant 2022; 41:1135.</a></li><li><a class="nounderline abstract_t">Zhang J, Lu J, Zhou X, et al. Perioperative Management of Pregnant Women With Idiopathic Pulmonary Arterial Hypertension: An Observational Case Series Study From China. J Cardiothorac Vasc Anesth 2018; 32:2547.</a></li><li><a class="nounderline abstract_t">Houston L, Tuuli M, Macones G. Marfan syndrome and aortic dissection in pregnancy. Obstet Gynecol 2011; 117:956.</a></li><li><a class="nounderline abstract_t">Buser RT, Mordecai MM, Brull SJ. Combined spinal-epidural analgesia for labor in a patient with Marfan's syndrome. Int J Obstet Anesth 2007; 16:274.</a></li><li><a class="nounderline abstract_t">Lacassie HJ, Millar S, Leithe LG, et al. Dural ectasia: a likely cause of inadequate spinal anaesthesia in two parturients with Marfan's syndrome. Br J Anaesth 2005; 94:500.</a></li><li><a class="nounderline abstract_t">Patel PA, Fernando RJ, Augoustides JG, et al. Acute Type-B Aortic Dissection in Pregnancy: Therapeutic Challenges in a Multidisciplinary Setting. J Cardiothorac Vasc Anesth 2017; 31:2268.</a></li><li><a class="nounderline abstract_t">Kikuchi Y, Kuroda M, Saito S. Anesthetic Management of Emergency Cesarean Delivery Followed Immediately by Thoracic Endovascular Aortic Repair for a Peripartum Dissecting Aorta Aneurysm With Impending Rupture (Stanford Type B Dissection) in a Pregnant Patient With Takayasu's Arteritis. J Cardiothorac Vasc Anesth 2020; 34:1897.</a></li></ol></div><div id="topicVersionRevision">Topic 93919 Version 35.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31022123" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : ACOG Practice Bulletin No. 212: Pregnancy and Heart Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165544" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30586767" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34046669" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21415725" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32381307" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Eisenmenger Syndrome in Pregnancy: A Management Conundrum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15321399" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : General anaesthesia using remifentanil for caesarean section in parturients with critical aortic stenosis: a series of four cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16394684" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Maternal and neonatal effects of remifentanil at induction of general anesthesia for cesarean delivery: a randomized, double-blind, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34023201" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Perioperative Management of the Fontan Patient for Cardiac and Noncardiac Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34425324" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Anesthetic management for the peripartum care of women with Fontan physiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21477759" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The adult with Fontan physiology: systematic approach to perioperative management for noncardiac surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21197552" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Anesthetic management of noncardiac surgery for patients with single ventricle physiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26086514" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Fontan physiology revisited.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27134136" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Adult patients with Fontan circulation: What we know and how to manage adults with Fontan circulation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16484266" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Pregnancy and congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23059960" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Haemodynamic effects from aortocaval compression at different angles of lateral tilt in non-labouring term pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19841302" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Peripheral vascular adaptation and orthostatic tolerance in Fontan physiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23965211" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Anesthetic care of parturients with single ventricle physiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29752389" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pregnancy in Women With a Fontan Circulation: A Systematic Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29935806" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : General Anesthetic Management for Emergency Cesarean Section and Postpartum Hemorrhage in a Woman With Fontan Circulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28501797" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Predictors of procedural complications in adult Fontan patients undergoing non-cardiac procedures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30021846" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Cardiomyopathy and Preeclampsia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16709208" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Maternal haemodynamics in pre-eclampsia compared with normal pregnancy during caesarean delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19444560" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A randomized study of the effects of perioperative i.v. lidocaine on hemodynamic and hormonal responses for cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22687592" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Anesthesia management of patients with hypertrophic obstructive cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36123001" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29525197" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Perioperative Management of Pregnant Women With Idiopathic Pulmonary Arterial Hypertension: An Observational Case Series Study From China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21422870" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Marfan syndrome and aortic dissection in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17337178" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Combined spinal-epidural analgesia for labor in a patient with Marfan's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15695549" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Dural ectasia: a likely cause of inadequate spinal anaesthesia in two parturients with Marfan's syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28666932" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Acute Type-B Aortic Dissection in Pregnancy: Therapeutic Challenges in a Multidisciplinary Setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31937478" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Anesthetic Management of Emergency Cesarean Delivery Followed Immediately by Thoracic Endovascular Aortic Repair for a Peripartum Dissecting Aorta Aneurysm With Impending Rupture (Stanford Type B Dissection) in a Pregnant Patient With Takayasu's Arteritis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
